CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 386 enrolled
Drug / intervention
Soy isoflavone supplement +1 moredrug
Likely dose
Soy isoflavone supplement 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01052116
NCT01052116Phase 4Completed
CompareCT.gov

The Study of Soy Isoflavones in Asthma

American Lung Association Asthma Clinical Research Centers·interventional·Posted Jan 20, 2010·Updated Jan 14, 2016

In Brief

A Phase 4 clinical trial evaluating Soy isoflavone supplement and Placebo for Asthma. Completed, enrolled 386 participants across 18 sites.

Detailed Summary

The trial is designed to study the effects of soy supplements on asthma control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 20, 2010
Enrollment StartMar 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 16.4 years ago

Interventions

Soy isoflavone supplementdrug

Oral soy isoflavone supplement (100 mg/day)

Placebodrug

Placebo